miR-143-5p as a Prognostic Biomarker in Colorectal Cancer: Inhibition of Tumor Progression Through Targeting MYCBP
Turkish Journal of Gastroenterology · 21.07.2026
DOI: 10.5152/tjg.2026.26198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, online erschienen am 21.07.2026. Verfasst von Chen Mu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Aims: miR-143-5p functions as a tumor-suppressive microRNA across various cancer types. The current study investigated the expression, prognostic value, and role of miR-143-5p in colorectal cancer (CRC). Materials and Methods: The expression of miR-143-5p was measured by quantitative reverse transcription polymerase chain reaction. Associations between miR-143-5p expression and clinicopathological characteristics of patients with CRC were statistically analyzed. A series of in vitro cell-based assays were performed to investigate the underlying regulatory mechanisms. Results: miR-143-5p was downregulated in CRC and may serve as a promising independent prognostic biomarker. Reduced miR- 143-5p expression was associated with adverse clinicopathological characteristics and decreased 5-year overall survival. MYCBP was identified as a direct target of miR-143-5p. Overexpression of miR-143-5p suppressed the malignant behaviors of CRC cells, which were partially restored by enforced MYCBP expression. Conclusion: miR-143-5p is downregulated in CRC and may function as a potential independent prognostic biomarker. Moreover, miR- 143-5p may play a tumor-suppressive role in CRC by specifically targeting MYCBP. Cite this article as: Mu C, Zhang H. MiR-143-5p as a prognostic biomarker in colorectal cancer: Inhibition of tumor progression through targeting MYCBP. Turk J Gastroenterol. Published online July 21, 2026. doi: 10.5152/tjg.2026.26198.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Pulmonary and Critical Care Medicine, The Eighth Medical Center of PLA General Hospital, Beijing, China.
Zitieren
APA
Mu, C., & Zhang, H. (2026). miR-143-5p as a Prognostic Biomarker in Colorectal Cancer: Inhibition of Tumor Progression Through Targeting MYCBP. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2026.26198
Vancouver
Mu C, Zhang H. miR-143-5p as a Prognostic Biomarker in Colorectal Cancer: Inhibition of Tumor Progression Through Targeting MYCBP. Turkish Journal of Gastroenterology. 2026. doi:10.5152/tjg.2026.26198
BibTeX
@article{Mu2026,
author = {Mu, Chen and Zhang, Han},
title = {miR-143-5p as a Prognostic Biomarker in Colorectal Cancer: Inhibition of Tumor Progression Through Targeting MYCBP},
journal = {Turkish Journal of Gastroenterology},
year = {2026},
doi = {10.5152/tjg.2026.26198}
}
EUVIMED